abrdn Healthcare Investors (NYSE:HQH – Get Free Report)’s stock price hit a new 52-week high during trading on Monday . The company traded as high as $22.31 and last traded at $22.1560, with a volume of 194715 shares. The stock had previously closed at $21.84.
abrdn Healthcare Investors Trading Up 1.4%
The company’s 50-day moving average price is $20.64 and its two-hundred day moving average price is $19.67.
abrdn Healthcare Investors Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Thursday, May 21st were paid a $0.61 dividend. This represents a $2.44 dividend on an annualized basis and a yield of 11.0%. The ex-dividend date of this dividend was Thursday, May 21st.
Institutional Investors Weigh In On abrdn Healthcare Investors
About abrdn Healthcare Investors
abrdn Healthcare Investors (NYSE:HQH) is a closed-end management investment company that seeks long-term capital appreciation and current income by investing primarily in equity securities of companies operating in the healthcare sector. The fund’s portfolio generally comprises a diversified mix of domestic and international healthcare issuers, spanning pharmaceuticals, biotechnology, medical devices, healthcare services, and related industries.
The fund employs a fundamental, research-driven approach to select investments, focusing on companies with strong balance sheets, innovative product pipelines and the potential for sustainable revenue growth.
Recommended Stories
- Five stocks we like better than abrdn Healthcare Investors
- SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control
- Why Rare Earth Processing Could Be the Real 2027 Opportunity
- The S&P 493 Are Staging a Comeback—This Value ETF Offers Broad Exposure
- TSMC Insiders Are Buying the Pullback—But Is the Signal as Bullish as It Looks?
Receive News & Ratings for abrdn Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for abrdn Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.
